MusthInsider

Latest On Syndax Pharmaceuticals, Inc (SNDX):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-09 04:24 EST	News	Syndax Pharmaceuticals GAAP EPS of -$0.59 beats by $0.01	N/A
2023-05-09 04:24 EST	News	Syndax Pharmaceuticals, Inc. (SNDX) Q1 2023 Earnings Call Transcript	N/A
2023-05-08 02:38 EST	News	Syndax Pharmaceuticals Q1 2023 Earnings Preview	N/A
2023-03-04 02:40 EST	News	Syndax Pharmaceuticals, Inc. (SNDX) Q4 2022 Earnings Call Transcript	N/A
2023-03-01 16:35 EST	News	Syndax Pharmaceuticals: 2023 Is A Pivotal Year	N/A
2023-03-01 01:25 EST	News	Syndax Pharmaceuticals GAAP EPS of -$0.62 beats by $0.04	N/A
2023-02-27 19:50 EST	News	Syndax Pharmaceuticals Q4 2022 Earnings Preview	N/A
2023-01-12 14:22 EST	News	Syndax Pharmaceuticals (SNDX) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- Slideshow	N/A
2022-12-17 03:56 EST	News	Syndax Pharmaceuticals (SNDX) Presents at 64th ASH Annual Meeting & Exposition	N/A
2022-12-12 19:48 EST	News	Kura Oncology falls, Syndax gains after Phase 1/2 data for leukemia candidates	N/A
2022-12-10 16:27 EST	News	Syndax Pharmaceuticals: Today's Best Nearby Biotech Cap-Gain Prospect	N/A
2022-12-07 20:58 EST	News	Syndax Pharmaceuticals prices $150M offering	N/A
2022-12-07 01:27 EST	News	Syndax Pharma to sell $150M stock in public offering	N/A
2022-12-05 14:27 EST	News	Syndax receives breakthrough therapy tag for revumenib to treat acute leukemia	N/A
2022-11-06 14:31 EST	News	Syndax Pharmaceuticals, Inc. (SNDX) Q3 2022 Earnings Call Transcript	N/A
2022-11-06 14:31 EST	News	Syndax Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation	N/A
2022-11-04 08:33 EST	News	Syndax Pharmaceuticals GAAP EPS of -$0.58 beats by $0.07; updates FY22 guidance	N/A
2022-11-02 23:19 EST	News	Syndax Pharmaceuticals Q3 2022 Earnings Preview	N/A
2022-08-09 08:07 EST	News	Syndax Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation	N/A
2022-08-09 08:07 EST	News	Syndax Pharmaceuticals GAAP EPS of -$0.62	N/A
2022-08-09 08:07 EST	News	Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q2 2022 Results - Earnings Call Transcript	N/A
2022-08-08 07:37 EST	News	Syndax Pharmaceuticals Q2 2022 Earnings Preview	N/A
2022-06-13 12:56 EST	News	Keith Goldan joins Syndax Pharmaceuticals as CFO	N/A
2022-05-10 14:01 EST	News	Syndax Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation	N/A
2022-05-10 14:01 EST	News	Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call Transcript	N/A
2022-05-09 16:51 EST	News	Syndax Pharmaceuticals GAAP EPS of -$0.63	N/A
2022-05-09 00:26 EST	News	Syndax Pharmaceuticals Q1 2022 Earnings Preview	N/A
2022-04-08 05:11 EST	News	Syndax Pharmaceuticals: Cash-Rich With 2 Promising Drugs	N/A
2022-03-25 00:25 EST	News	Syndax Pharmaceuticals (SNDX) Presents At Barclays Global Healthcare Conference	N/A
2022-03-02 06:49 EST	News	Syndax appoints former Alnylam executive as new medical chief	N/A
2022-03-02 06:49 EST	News	Syndax Pharmaceuticals GAAP EPS of $1.81 beats by $1.84, revenue of $126.6M beats by $67.92M	N/A
2022-03-02 06:48 EST	News	Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call Transcript	N/A
2022-02-28 18:56 EST	News	Syndax Pharmaceuticals Q4 Earnings Preview	N/A
2022-01-29 06:36 EST	News	Syndax Pharmaceuticals (SNDX) Investor Presentation - Slideshow	N/A
2021-12-23 00:22 EST	News	Syndax's SNDX-5613 an Orphan Drug in Europe for acute myeloid leukemia	N/A
2021-12-16 14:02 EST	News	Syndax Pharma raises $75M via stock offering	N/A
2021-12-15 18:28 EST	News	Syndax Pharmaceuticals drops 6% following underwritten stock offering	N/A
2021-11-16 08:01 EST	News	Syndax Pharmaceuticals EPS misses by $0.35, misses on revenue	N/A
2021-11-16 08:01 EST	News	Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2021 Results - Earnings Call Transcript	N/A
2021-11-16 08:01 EST	News	Syndax Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation	N/A
2021-11-14 18:13 EST	News	Syndax Pharmaceuticals Q3 2021 Earnings Preview	N/A
2021-11-04 16:35 EST	News	Syndax Pharma falls after updating early-stage data for leukemia therapy	N/A
2021-10-05 15:59 EST	News	Syndax Pharma CFO Daphne Karydas to resign to pursue another opportunity	N/A
2021-09-28 02:06 EST	News	Incyte and Syndax in pact for xatilimab targeting immune-related conditions	N/A
2021-08-10 12:01 EST	News	Syndax Pharmaceuticals EPS beats by $0.28, beats on revenue	N/A
2021-08-10 12:00 EST	News	Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q2 2021 Results - Earnings Call Transcript	N/A
2021-08-10 11:59 EST	News	Syndax Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call Presentation	N/A
2021-07-22 02:04 EST	News	Syndax Pharmaceuticals: Updated Analysis After Reporting Interim Phase 1 Data	N/A
2021-07-22 02:02 EST	News	Canopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst action	N/A
2021-07-22 01:35 EST	News	Syndax shares rise on FDA Fast Track status for leukemia treatment SNDX-5613	N/A

About Syndax Pharmaceuticals, Inc (SNDX):

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. The company was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

See Advanced Chart

General

Name Syndax Pharmaceuticals, Inc
Symbol SNDX
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 43
Fiscal Year EndDecember
IPO Date2016-03-03
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://www.syndax.com

Valuation

Price/Sales (Trailing 12 Mt.) 634.74
Price/Book (Most Recent Quarter) 4.43
Enterprise Value Revenue 542.55

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$2.19
Next Year EPS Estimate -$2.17
Next Quarter EPS Estimate -$0.47
Operating Margin -4708%
Return on Assets -25%
Return on Equity -52%
Revenue 1.52 million
Earnings Per Share -$2.36
Revenue Per Share $0.04
Gross Profit 1.52 million
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 1.16 billion
EBITDA -67280000
PE Ratio -125.39
Analyst Target Price $32.14
Book Value Per Share $5.27

Share Statistics

Shares Outstanding 48.24 million
Shares Float 42.95 million
% Held by Insiders 645%
% Held by Institutions 78.88%
Shares Short 4.93 million
Shares Short Prior Month 4.93 million
Short Ratio 9.27
Short % of Float 11%
Short % of Shares Outstanding 10%

Technicals

Beta 1.84
52 Week High $27.12
52 Week Low $8.18
50 Day Moving Average 22.33
200 Day Moving Average 20.55

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Syndax Pharmaceuticals, Inc (SNDX) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Syndax Pharmaceuticals, Inc (SNDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-08	$380000	-$0.44	-$0.51	13.23%
2020-09-30	2020-11-02	$N/A	-$0.46	-$0.43	-6.75%
2020-06-30	2020-08-06	$N/A	-$0.42	-$0.44	4.76%
2020-03-31	2020-05-07	$379000	-$0.56	-$0.53	-6.65%
2019-12-31	2020-03-03	$380000	-$0.44	-$0.43	-1.31%
2019-09-30	2019-11-07	$379000	-$0.41	-$0.48	13.92%
2019-06-30	2019-08-07	$379000	-$0.47	-$0.47	0.76%
2019-03-31	2019-05-06	$379000	-$0.53	-$0.55	4.14%
2018-12-31	2019-03-07	$379000	-$0.70	-$0.64	-9.43%
2018-09-30	2018-11-05	$379000	-$0.68	-$0.76	10.21%
2018-06-30	2018-08-07	$379000	-$0.74	-$0.89	16.94%
2018-03-31	2018-05-08	$379000	-$0.79	-$0.95	17.15%
2017-12-31	2018-03-05	$1.19 million	-$0.80	-$0.77	-3.67%
2017-09-30	2017-11-07	$305000	-$0.68	-$0.82	16.63%
2017-06-30	2017-08-10	$305000	-$0.70	-$0.82	14.83%
2017-03-31	2017-05-08	$305000	-$0.71	-$0.71	0.56%
2016-12-31	2017-03-02	$305000	-$0.59	-$0.74	19.79%
2016-09-30	2016-11-10	$305000	-$0.84	-$0.82	-2.78%
2016-06-30	2016-08-09	$305000	-$0.47	-$0.54	12.18%
2016-03-31	2016-05-16	$305000	-$0.73	-$0.48	-52.22%

Syndax Pharmaceuticals, Inc (SNDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Syndax Pharmaceuticals, Inc (SNDX) Chart:

Syndax Pharmaceuticals, Inc (SNDX) News:

Below you will find a list of latest news for Syndax Pharmaceuticals, Inc (SNDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Syndax Pharmaceuticals, Inc (SNDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2026-02-20	13	8.6	CALL	0	3	0	TRUE	0	0
2026-02-20	14	7.37	CALL	0	5	0	TRUE	0	0
2026-02-20	15	5.6	CALL	0	2	0	TRUE	0	0
2026-02-20	16	6.37	CALL	0	22	53.03	TRUE	0	0
2026-02-20	17	0	CALL	0	0	67.21	TRUE	0	0
2026-02-20	18	3.57	CALL	0	4	65.4	TRUE	0	0
2026-02-20	19	0	CALL	0	0	70.51	TRUE	0	0
2026-02-20	20	1.5	CALL	0	235	63.45	TRUE	0	0
2026-02-20	21	1.27	CALL	484	67	62.02	FALSE	0.05	0.04
2026-02-20	22	1	CALL	8	29	66.38	FALSE	1	0
2026-02-20	23	0.95	CALL	69	24	77.47	FALSE	0.35	0.58
2026-02-20	24	0.45	CALL	11	3	63.63	FALSE	0.05	0.13
2026-02-20	25	0.45	CALL	260	591	73.05	FALSE	-0.05	-0.1
2026-02-20	26	0.24	CALL	0	70	109.38	FALSE	0	0
2026-02-20	27	0	CALL	0	0	207.72	FALSE	0	0
2026-02-20	28	0	CALL	0	0	289.84	FALSE	0	0
2026-02-20	29	0.18	CALL	3	27	81.62	FALSE	0.04	0.29
2026-02-20	13	0	PUT	0	0	115.24	FALSE	0	0
2026-02-20	14	0	PUT	0	0	415.2	FALSE	0	0
2026-02-20	15	0	PUT	0	0	72.3	FALSE	0	0
2026-02-20	16	0	PUT	0	0	81.31	FALSE	0	0
2026-02-20	17	0	PUT	0	0	310.75	FALSE	0	0
2026-02-20	18	0.46	PUT	10	10	62.96	FALSE	0.46	0
2026-02-20	19	0.81	PUT	0	422	90.71	FALSE	0	0
2026-02-20	20	1.49	PUT	0	62	117.34	FALSE	0	0
2026-02-20	21	1.95	PUT	0	27	195.91	TRUE	0	0
2026-02-20	22	0	PUT	0	0	68.81	TRUE	0	0
2026-02-20	23	0	PUT	0	0	68.39	TRUE	0	0
2026-02-20	24	0	PUT	0	0	75.98	TRUE	0	0
2026-02-20	25	0	PUT	0	0	71.85	TRUE	0	0
2026-02-20	26	0	PUT	0	0	73.69	TRUE	0	0
2026-02-20	27	0	PUT	0	0	68.36	TRUE	0	0
2026-02-20	28	0	PUT	0	0	88.64	TRUE	0	0
2026-02-20	29	0	PUT	0	0	95.45	TRUE	0	0
2026-03-20	12	0	CALL	0	0	56.04	TRUE	0	0
2026-03-20	13	0	CALL	0	0	63.1	TRUE	0	0
2026-03-20	14	0	CALL	0	0	80.61	TRUE	0	0
2026-03-20	15	0	CALL	0	0	69.03	TRUE	0	0
2026-03-20	16	0	CALL	0	0	70.99	TRUE	0	0
2026-03-20	17	0	CALL	0	0	74.72	TRUE	0	0
2026-03-20	18	0	CALL	0	0	75.77	TRUE	0	0
2026-03-20	19	0	CALL	0	0	78.47	TRUE	0	0
2026-03-20	20	0	CALL	0	0	69.21	TRUE	0	0
2026-03-20	21	0	CALL	0	0	83.14	FALSE	0	0
2026-03-20	22	0	CALL	0	0	164.6	FALSE	0	0
2026-03-20	23	0	CALL	0	0	86.79	FALSE	0	0
2026-03-20	24	1.4	CALL	0	6	149.82	FALSE	0	0
2026-03-20	25	1.15	CALL	0	2	192.15	FALSE	0	0
2026-03-20	26	0	CALL	0	0	199.96	FALSE	0	0
2026-03-20	27	0	CALL	0	0	207.24	FALSE	0	0
2026-03-20	28	0	CALL	0	0	214.06	FALSE	0	0
2026-03-20	12	0	PUT	0	0	179.63	FALSE	0	0
2026-03-20	13	0	PUT	0	0	324.31	FALSE	0	0
2026-03-20	14	0	PUT	0	0	299.59	FALSE	0	0
2026-03-20	15	0	PUT	0	0	272.54	FALSE	0	0
2026-03-20	16	0	PUT	0	0	247.64	FALSE	0	0
2026-03-20	17	0	PUT	0	0	224.44	FALSE	0	0
2026-03-20	18	0	PUT	0	0	82.07	FALSE	0	0
2026-03-20	19	0	PUT	0	0	171.49	FALSE	0	0
2026-03-20	20	0	PUT	0	0	151.81	FALSE	0	0
2026-03-20	21	0	PUT	0	0	70.34	TRUE	0	0
2026-03-20	22	0	PUT	0	0	72.29	TRUE	0	0
2026-03-20	23	0	PUT	0	0	79.5	TRUE	0	0
2026-03-20	24	0	PUT	0	0	69.16	TRUE	0	0
2026-03-20	25	0	PUT	0	0	77.91	TRUE	0	0
2026-03-20	26	0	PUT	0	0	70.35	TRUE	0	0
2026-03-20	27	0	PUT	0	0	68.1	TRUE	0	0
2026-03-20	28	0	PUT	0	0	78.3	TRUE	0	0
2026-04-17	1	0	CALL	0	0	0	TRUE	0	0
2026-04-17	2	0	CALL	0	0	0	TRUE	0	0
2026-04-17	3	0	CALL	0	0	0	TRUE	0	0
2026-04-17	4	0	CALL	0	0	0	TRUE	0	0
2026-04-17	5	0	CALL	0	0	0	TRUE	0	0
2026-04-17	6	0	CALL	0	0	0	TRUE	0	0
2026-04-17	7	7.8	CALL	0	1	0	TRUE	0	0
2026-04-17	8	0	CALL	0	0	0	TRUE	0	0
2026-04-17	9	0	CALL	0	0	0	TRUE	0	0
2026-04-17	10	10.35	CALL	0	408	0	TRUE	0	0
2026-04-17	11	10.4	CALL	0	6	63.34	TRUE	0	0
2026-04-17	12	8.52	CALL	0	17	70.45	TRUE	0	0
2026-04-17	13	8.6	CALL	0	100	70.09	TRUE	0	0
2026-04-17	14	8.27	CALL	0	13	60.33	TRUE	0	0
2026-04-17	15	6.2	CALL	4	353	70.36	TRUE	-0.1	-0.02
2026-04-17	16	5.2	CALL	0	432	62.12	TRUE	0	0
2026-04-17	17	4.25	CALL	0	151	59.3	TRUE	0	0
2026-04-17	18	3.75	CALL	0	114	46.29	TRUE	0	0
2026-04-17	19	4.1	CALL	0	49	56.69	TRUE	0	0
2026-04-17	20	2.9	CALL	0	134	60.01	TRUE	0	0
2026-04-17	21	2.73	CALL	0	32	63.85	FALSE	0	0
2026-04-17	22	2.57	CALL	0	28	134.63	FALSE	0	0
2026-04-17	23	2.4	CALL	0	86	142.87	FALSE	0	0
2026-04-17	24	1.5	CALL	1	8	66.61	FALSE	1.5	0
2026-04-17	25	1.2	CALL	0	679	127.02	FALSE	0	0
2026-04-17	26	1.25	CALL	0	47	161.22	FALSE	0	0
2026-04-17	27	2.05	CALL	0	7	164.69	FALSE	0	0
2026-04-17	28	0.8	CALL	0	22	126.08	FALSE	0	0
2026-04-17	29	0	CALL	0	0	100.77	FALSE	0	0
2026-04-17	30	0.64	CALL	14	147	72.27	FALSE	0.04	0.07
2026-04-17	31	0	CALL	0	0	98.17	FALSE	0	0
2026-04-17	32	1.2	CALL	0	1	105.27	FALSE	0	0
2026-04-17	33	0	CALL	0	0	127.95	FALSE	0	0
2026-04-17	34	1.05	CALL	0	1	148.13	FALSE	0	0
2026-04-17	35	0	CALL	0	0	207.06	FALSE	0	0
2026-04-17	1	0	PUT	0	0	316.02	FALSE	0	0
2026-04-17	2	0	PUT	0	0	0	FALSE	0	0
2026-04-17	3	0	PUT	0	0	0	FALSE	0	0
2026-04-17	4	0	PUT	0	0	0	FALSE	0	0
2026-04-17	5	0	PUT	0	0	673.8	FALSE	0	0
2026-04-17	6	0	PUT	0	0	540.73	FALSE	0	0
2026-04-17	7	0	PUT	0	0	540.45	FALSE	0	0
2026-04-17	8	0	PUT	0	0	465.48	FALSE	0	0
2026-04-17	9	0	PUT	0	0	358.16	FALSE	0	0
2026-04-17	10	0.9	PUT	0	333	326.76	FALSE	0	0
2026-04-17	11	0.9	PUT	0	43	280.22	FALSE	0	0
2026-04-17	12	2.15	PUT	0	13	218.92	FALSE	0	0
2026-04-17	13	1.4	PUT	0	63	258.84	FALSE	0	0
2026-04-17	14	0.55	PUT	0	111	71.28	FALSE	0	0
2026-04-17	15	1.1	PUT	0	26	224.61	FALSE	0	0
2026-04-17	16	0.95	PUT	0	314	76.06	FALSE	0	0
2026-04-17	17	2.3	PUT	0	58	67.56	FALSE	0	0
2026-04-17	18	1.6	PUT	0	16	111.66	FALSE	0	0
2026-04-17	19	2	PUT	1	220	72.64	FALSE	2	0
2026-04-17	20	2.25	PUT	8	15	66.09	FALSE	0.03	0.01
2026-04-17	21	4.5	PUT	0	3	50.91	TRUE	0	0
2026-04-17	22	3.7	PUT	0	8	54.49	TRUE	0	0
2026-04-17	23	0	PUT	0	0	69.4	TRUE	0	0
2026-04-17	24	0	PUT	0	0	73.81	TRUE	0	0
2026-04-17	25	0	PUT	0	0	76.06	TRUE	0	0
2026-04-17	26	0	PUT	0	0	68.27	TRUE	0	0
2026-04-17	27	0	PUT	0	0	75.3	TRUE	0	0
2026-04-17	28	0	PUT	0	0	75.88	TRUE	0	0
2026-04-17	29	0	PUT	0	0	79.06	TRUE	0	0
2026-04-17	30	0	PUT	0	0	83.55	TRUE	0	0
2026-04-17	31	0	PUT	0	0	65.75	TRUE	0	0
2026-04-17	32	0	PUT	0	0	84.65	TRUE	0	0
2026-04-17	33	0	PUT	0	0	84.45	TRUE	0	0
2026-04-17	34	0	PUT	0	0	76.1	TRUE	0	0
2026-04-17	35	0	PUT	0	0	68.86	TRUE	0	0
2026-07-17	5	0	CALL	0	0	0	TRUE	0	0
2026-07-17	9	0	CALL	0	0	64.68	TRUE	0	0
2026-07-17	10	0	CALL	0	0	66.53	TRUE	0	0
2026-07-17	11	0	CALL	0	0	71.33	TRUE	0	0
2026-07-17	12	11	CALL	0	3	71.99	TRUE	0	0
2026-07-17	13	0	CALL	0	0	68.94	TRUE	0	0
2026-07-17	14	0	CALL	0	0	74.58	TRUE	0	0
2026-07-17	15	0	CALL	0	0	69.52	TRUE	0	0
2026-07-17	16	0	CALL	0	0	69.15	TRUE	0	0
2026-07-17	17	0	CALL	0	0	68.88	TRUE	0	0
2026-07-17	18	5.5	CALL	10	89	74.83	TRUE	5.5	0
2026-07-17	19	0	CALL	0	0	71.55	TRUE	0	0
2026-07-17	20	4.5	CALL	0	8	74.76	TRUE	0	0
2026-07-17	21	3.6	CALL	0	6	73.03	FALSE	0	0
2026-07-17	22	4	CALL	0	10	70.75	FALSE	0	0
2026-07-17	23	3.35	CALL	0	5	76.72	FALSE	0	0
2026-07-17	24	3.95	CALL	0	52	72.9	FALSE	0	0
2026-07-17	25	2.65	CALL	0	21	75.2	FALSE	0	0
2026-07-17	26	2.78	CALL	0	73	74.41	FALSE	0	0
2026-07-17	27	0	CALL	0	0	117.34	FALSE	0	0
2026-07-17	28	0	CALL	0	0	121.27	FALSE	0	0
2026-07-17	29	1.66	CALL	0	2	123.22	FALSE	0	0
2026-07-17	30	1.55	CALL	0	42	83.1	FALSE	0	0
2026-07-17	31	1.7	CALL	0	1	123.01	FALSE	0	0
2026-07-17	32	1.3	CALL	0	1	102.2	FALSE	0	0
2026-07-17	33	1.05	CALL	0	4	136.17	FALSE	0	0
2026-07-17	34	0	CALL	0	0	140.77	FALSE	0	0
2026-07-17	35	1.55	CALL	0	2	106.01	FALSE	0	0
2026-07-17	5	0	PUT	0	0	507.54	FALSE	0	0
2026-07-17	9	0	PUT	0	0	274.07	FALSE	0	0
2026-07-17	10	0	PUT	0	0	206.84	FALSE	0	0
2026-07-17	11	0	PUT	0	0	228.33	FALSE	0	0
2026-07-17	12	0	PUT	0	0	210.07	FALSE	0	0
2026-07-17	13	0	PUT	0	0	190.91	FALSE	0	0
2026-07-17	14	0	PUT	0	0	173.79	FALSE	0	0
2026-07-17	15	0	PUT	0	0	158.25	FALSE	0	0
2026-07-17	16	1.6	PUT	0	1	141.63	FALSE	0	0
2026-07-17	17	1.75	PUT	0	5	119.72	FALSE	0	0
2026-07-17	18	2.1	PUT	0	8	71.1	FALSE	0	0
2026-07-17	19	2.75	PUT	0	33	70.69	FALSE	0	0
2026-07-17	20	0	PUT	0	0	71.83	FALSE	0	0
2026-07-17	21	3.7	PUT	0	12	70.84	TRUE	0	0
2026-07-17	22	0	PUT	0	0	75.45	TRUE	0	0
2026-07-17	23	0	PUT	0	0	73.2	TRUE	0	0
2026-07-17	24	5.7	PUT	0	4	68.21	TRUE	0	0
2026-07-17	25	0	PUT	0	0	72.42	TRUE	0	0
2026-07-17	26	0	PUT	0	0	69.01	TRUE	0	0
2026-07-17	27	0	PUT	0	0	73.32	TRUE	0	0
2026-07-17	28	0	PUT	0	0	67.92	TRUE	0	0
2026-07-17	29	0	PUT	0	0	74.51	TRUE	0	0
2026-07-17	30	0	PUT	0	0	76.07	TRUE	0	0
2026-07-17	31	0	PUT	0	0	71.19	TRUE	0	0
2026-07-17	32	0	PUT	0	0	74.25	TRUE	0	0
2026-07-17	33	0	PUT	0	0	77.17	TRUE	0	0
2026-07-17	34	0	PUT	0	0	77.76	TRUE	0	0
2026-07-17	35	0	PUT	0	0	67.88	TRUE	0	0
2027-01-15	3	0	CALL	0	0	0	TRUE	0	0
2027-01-15	5	0	CALL	0	0	101.28	TRUE	0	0
2027-01-15	8	13	CALL	0	17	77.84	TRUE	0	0
2027-01-15	10	12.3	CALL	0	44	84.78	TRUE	0	0
2027-01-15	13	9.58	CALL	0	159	75.55	TRUE	0	0
2027-01-15	15	7.95	CALL	0	175	73.02	TRUE	0	0
2027-01-15	17	8	CALL	0	16	72.86	TRUE	0	0
2027-01-15	20	7	CALL	0	135	76.35	TRUE	0	0
2027-01-15	22	5.5	CALL	1	3316	72.36	FALSE	0	0
2027-01-15	25	4.75	CALL	0	20	82.32	FALSE	0	0
2027-01-15	27	4.2	CALL	1	66	73.61	FALSE	4.2	0
2027-01-15	30	2	CALL	0	25	74.14	FALSE	0	0
2027-01-15	32	0	CALL	0	0	74.34	FALSE	0	0
2027-01-15	35	0	CALL	0	0	77.17	FALSE	0	0
2027-01-15	37	0	CALL	0	0	105.69	FALSE	0	0
2027-01-15	40	2.23	CALL	0	2	110.61	FALSE	0	0
2027-01-15	3	0	PUT	0	0	171.97	FALSE	0	0
2027-01-15	5	0	PUT	0	0	0	FALSE	0	0
2027-01-15	8	0	PUT	0	0	241.84	FALSE	0	0
2027-01-15	10	0	PUT	0	0	189.54	FALSE	0	0
2027-01-15	13	3.7	PUT	0	5	140.68	FALSE	0	0
2027-01-15	15	4.45	PUT	0	15	117	FALSE	0	0
2027-01-15	17	0	PUT	0	0	73.86	FALSE	0	0
2027-01-15	20	5.5	PUT	0	1	74.86	FALSE	0	0
2027-01-15	22	0	PUT	0	0	74.79	TRUE	0	0
2027-01-15	25	7.45	PUT	0	8	74.18	TRUE	0	0
2027-01-15	27	0	PUT	0	0	74.69	TRUE	0	0
2027-01-15	30	11.5	PUT	0	39	70.78	TRUE	0	0
2027-01-15	32	0	PUT	0	0	75.77	TRUE	0	0
2027-01-15	35	0	PUT	0	0	75.92	TRUE	0	0
2027-01-15	37	0	PUT	0	0	72.92	TRUE	0	0
2027-01-15	40	0	PUT	0	0	70.75	TRUE	0	0
2028-01-21	3	0	CALL	0	0	95.83	TRUE	0	0
2028-01-21	5	0	CALL	0	0	89.09	TRUE	0	0
2028-01-21	8	0	CALL	0	0	77.26	TRUE	0	0
2028-01-21	10	12.4	CALL	0	108	74.98	TRUE	0	0
2028-01-21	13	6	CALL	0	1	74.86	TRUE	0	0
2028-01-21	15	0	CALL	0	0	73.03	TRUE	0	0
2028-01-21	17	8.72	CALL	0	10	76.28	TRUE	0	0
2028-01-21	20	8.5	CALL	0	106	76.15	TRUE	0	0
2028-01-21	22	7.9	CALL	0	1	71.98	FALSE	0	0
2028-01-21	25	6.5	CALL	0	2	74.72	FALSE	0	0
2028-01-21	27	0	CALL	0	0	74.35	FALSE	0	0
2028-01-21	30	5.7	CALL	0	102	70.97	FALSE	0	0
2028-01-21	32	0	CALL	0	0	72.03	FALSE	0	0
2028-01-21	35	4	CALL	1	0	61.22	FALSE	4	0
2028-01-21	37	0	CALL	0	0	72.46	FALSE	0	0
2028-01-21	40	0	CALL	0	0	71.65	FALSE	0	0
2028-01-21	3	0	PUT	0	0	0	FALSE	0	0
2028-01-21	5	0	PUT	0	0	0	FALSE	0	0
2028-01-21	8	0	PUT	0	0	174.95	FALSE	0	0
2028-01-21	10	2.71	PUT	0	3	137.1	FALSE	0	0
2028-01-21	13	2.9	PUT	0	72	58.93	FALSE	0	0
2028-01-21	15	3.2	PUT	0	2	72.56	FALSE	0	0
2028-01-21	17	4.47	PUT	0	12	71.28	FALSE	0	0
2028-01-21	20	5.58	PUT	0	0	73.16	FALSE	0	0
2028-01-21	22	0	PUT	0	0	70.1	TRUE	0	0
2028-01-21	25	0	PUT	0	0	69.46	TRUE	0	0
2028-01-21	27	0	PUT	0	0	69.91	TRUE	0	0
2028-01-21	30	0	PUT	0	0	72.01	TRUE	0	0
2028-01-21	32	0	PUT	0	0	71.46	TRUE	0	0
2028-01-21	35	0	PUT	0	0	72.18	TRUE	0	0
2028-01-21	37	0	PUT	0	0	70.85	TRUE	0	0
2028-01-21	40	21.35	PUT	0	28	70.65	TRUE	0	0

Latest SNDX Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	3	$15.6
Jun 13, 2022 7:59 PM EST	4	$15.6
Jun 13, 2022 7:59 PM EST	1	$15.6
Jun 13, 2022 7:59 PM EST	100	$15.61
Jun 13, 2022 7:59 PM EST	45	$15.61

Syndax Pharmaceuticals, Inc (SNDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-06-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2019-09-05	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1395937/000000000019013216/0000000000-19-013216-index.htm
2019-02-08	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000021545719006549/0000215457-19-006549-index.htm
2020-02-06	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000083423720006818/0000834237-20-006818-index.htm
2020-09-09	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000083423720010194/0000834237-20-010194-index.htm
2019-02-12	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000090221919000254/0000902219-19-000254-index.htm
2020-01-28	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000090221920000308/0000902219-20-000308-index.htm
2019-04-08	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000090266419001816/0000902664-19-001816-index.htm
2020-02-12	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000090266420000971/0000902664-20-000971-index.htm
2020-11-04	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000091957420006675/0000919574-20-006675-index.htm
2018-06-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000092189518001976/0000921895-18-001976-index.htm
2018-11-29	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000092189518003173/0000921895-18-003173-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000092189519000467/0000921895-19-000467-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000092189520000574/0000921895-20-000574-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000101359419000160/0001013594-19-000160-index.htm
2020-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000101359420000127/0001013594-20-000127-index.htm
2018-04-10	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1395937/000114036118018005/0001140361-18-018005-index.htm
2018-04-10	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1395937/000114036118018007/0001140361-18-018007-index.htm
2018-06-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000119312518197997/0001193125-18-197997-index.htm
2019-02-12	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000119312519034379/0001193125-19-034379-index.htm
2019-03-28	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1395937/000119312519088951/0001193125-19-088951-index.htm
2019-03-29	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000119312519092679/0001193125-19-092679-index.htm
2019-03-29	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1395937/000119312519092701/0001193125-19-092701-index.htm
2019-08-30	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1395937/000119312519235283/0001193125-19-235283-index.htm
2019-09-06	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1395937/000119312519239953/0001193125-19-239953-index.htm
2019-09-10	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1395937/000119312519242045/0001193125-19-242045-index.htm
2019-10-09	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000119312519265254/0001193125-19-265254-index.htm
2020-02-03	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1395937/000119312520022917/0001193125-20-022917-index.htm
2020-02-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000119312520023646/0001193125-20-023646-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000119312520037637/0001193125-20-037637-index.htm
2020-05-11	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1395937/000119312520139263/0001193125-20-139263-index.htm
2018-04-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2018-05-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018002680/0001562180-18-002680-index.htm
2018-05-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018002681/0001562180-18-002681-index.htm
2018-05-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018002682/0001562180-18-002682-index.htm
2018-05-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018002683/0001562180-18-002683-index.htm
2018-05-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018002684/0001562180-18-002684-index.htm
2018-05-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018002685/0001562180-18-002685-index.htm
2018-09-27	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018004047/0001562180-18-004047-index.htm
2018-09-27	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018004048/0001562180-18-004048-index.htm
2018-09-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018004049/0001562180-18-004049-index.htm
2018-09-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018004050/0001562180-18-004050-index.htm
2018-11-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-02-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019000852/0001562180-19-000852-index.htm
2019-02-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019000853/0001562180-19-000853-index.htm
2019-02-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019000854/0001562180-19-000854-index.htm
2019-02-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019000855/0001562180-19-000855-index.htm
2019-02-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019000856/0001562180-19-000856-index.htm
2019-03-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-25	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019002023/0001562180-19-002023-index.htm
2019-05-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2019-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019003487/0001562180-19-003487-index.htm
2019-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019003488/0001562180-19-003488-index.htm
2019-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019003489/0001562180-19-003489-index.htm
2019-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019003490/0001562180-19-003490-index.htm
2019-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019003491/0001562180-19-003491-index.htm
2019-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019003492/0001562180-19-003492-index.htm
2019-07-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019003880/0001562180-19-003880-index.htm
2019-10-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001228/0001562180-20-001228-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001229/0001562180-20-001229-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001230/0001562180-20-001230-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001231/0001562180-20-001231-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001232/0001562180-20-001232-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001233/0001562180-20-001233-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001234/0001562180-20-001234-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001235/0001562180-20-001235-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001236/0001562180-20-001236-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001237/0001562180-20-001237-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-07-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-07-13	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020005102/0001562180-20-005102-index.htm
2020-11-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2018-03-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459018004520/0001564590-18-004520-index.htm
2018-03-08	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1395937/000156459018004911/0001564590-18-004911-index.htm
2018-05-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459018011784/0001564590-18-011784-index.htm
2018-05-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459018012378/0001564590-18-012378-index.htm
2018-05-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459018014349/0001564590-18-014349-index.htm
2018-08-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459018019907/0001564590-18-019907-index.htm
2018-08-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459018020483/0001564590-18-020483-index.htm
2018-08-08	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1395937/000156459018020504/0001564590-18-020504-index.htm
2018-09-26	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459018023593/0001564590-18-023593-index.htm
2018-11-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459018026817/0001564590-18-026817-index.htm
2018-11-05	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459018026892/0001564590-18-026892-index.htm
2019-02-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459019002676/0001564590-19-002676-index.htm
2019-03-07	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1395937/000156459019006772/0001564590-19-006772-index.htm
2019-03-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459019006777/0001564590-19-006777-index.htm
2019-03-18	10-K/A	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1395937/000156459019008313/0001564590-19-008313-index.htm
2019-04-30	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1395937/000156459019014263/0001564590-19-014263-index.htm
2019-05-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459019015972/0001564590-19-015972-index.htm
2019-05-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459019017318/0001564590-19-017318-index.htm
2019-06-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459019022241/0001564590-19-022241-index.htm
2019-07-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459019024625/0001564590-19-024625-index.htm
2019-08-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459019030050/0001564590-19-030050-index.htm
2019-08-07	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459019030067/0001564590-19-030067-index.htm
2019-08-07	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1395937/000156459019030084/0001564590-19-030084-index.htm
2019-10-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459019036518/0001564590-19-036518-index.htm
2019-11-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459019041712/0001564590-19-041712-index.htm
2019-11-07	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459019041719/0001564590-19-041719-index.htm
2019-12-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459019045581/0001564590-19-045581-index.htm
2020-02-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020004037/0001564590-20-004037-index.htm
2020-02-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020005551/0001564590-20-005551-index.htm
2020-03-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020008426/0001564590-20-008426-index.htm
2020-03-05	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1395937/000156459020009016/0001564590-20-009016-index.htm
2020-04-29	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1395937/000156459020019694/0001564590-20-019694-index.htm
2020-04-30	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459020019928/0001564590-20-019928-index.htm
2020-04-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020019941/0001564590-20-019941-index.htm
2020-05-04	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459020020574/0001564590-20-020574-index.htm
2020-05-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020020633/0001564590-20-020633-index.htm
2020-05-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020022849/0001564590-20-022849-index.htm
2020-05-07	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459020022971/0001564590-20-022971-index.htm
2020-06-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2020-07-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020031882/0001564590-20-031882-index.htm
2020-08-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020037719/0001564590-20-037719-index.htm
2020-08-06	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1395937/000156459020037767/0001564590-20-037767-index.htm
2020-08-06	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459020037777/0001564590-20-037777-index.htm
2020-11-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1395937/000156459020049638/0001564590-20-049638-index.htm
2020-11-05	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1395937/000156459020051287/0001564590-20-051287-index.htm
2019-09-10	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1395937/999999999519002056/9999999995-19-002056-index.htm
2018-11-27	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1395937/999999999716026189/9999999997-16-026189-index.htm
2018-04-03	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1395937/999999999718004150/9999999997-18-004150-index.htm
2018-06-13	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1395937/999999999718006372/9999999997-18-006372-index.htm
2018-08-29	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1395937/999999999718007508/9999999997-18-007508-index.htm
2018-12-20	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1395937/999999999718009113/9999999997-18-009113-index.htm
2019-03-28	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1395937/999999999719002097/9999999997-19-002097-index.htm

Syndax Pharmaceuticals, Inc (SNDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syndax Pharmaceuticals, Inc (SNDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 645%
Institutional Ownership: 7888%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2018-04-03	Peter Ordentlich	Chief Scientific Officer	Sell	7,500.00	15.00	112,500.00	0.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2020-07-06	Michael L. Meyers	SVP, Chief Medical Officer	Buy	3,500.00			10,730.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-11-04	Michael A Metzger	President and COO	Buy	100,000.00	7.20	720,000.00	117,659.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-09	Briggs Morrison	Chief Executive Officer	Buy	13,200.00	7.56	99,726.00	13,200.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2020-02-12	Michael A Metzger	President and COO	Buy	15,000.00			17,659.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-11-04	Michael A Metzger	President and COO	Sell	100,000.00	20.31	2,031,410.00	17,659.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-13	Briggs Morrison	Chief Executive Officer	Buy	7,200.00	7.29	52,516.80	20,400.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2018-10-30	Michael L. Meyers	SVP, Chief Medical Officer	Buy	200.00	4.79	958.00	2,398.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-10-10	Briggs Morrison	Chief Executive Officer	Buy	11,000.00	5.40	59,400.00	31,400.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-04	Briggs Morrison	Chief Executive Officer	Buy	12,500.00	8.00	100,000.00	43,900.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2019-03-21	Michael L. Meyers	SVP, Chief Medical Officer	Buy	1,000.00	4.93	4,930.00	7,118.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-21	Michael L. Meyers	SVP, Chief Medical Officer	Buy	104.00	4.87	506.48	7,222.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2018-04-03	Peter Ordentlich	Chief Scientific Officer	Buy	7,500.00	3.08	23,100.00	7,500.00	https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm

Syndax Pharmaceuticals, Inc

(NASDAQ:SNDX)